SynthesisJAMA2013
Insomnia.
Synthesis in JAMA, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 443 papers, 16 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
CBT-I for Psychosis: Guidelines, Preliminary Efficacy, and Functional Outcomes
Non-inferiority Study of Telemedicine Versus Conventional CBT-I in Recently Hospitalized Patients With Insomnia
Faecal Microbiota Transplantation for Insomnia Disorder: a Randomized, Double-blind, Placebo-controlled Trial
Who cites it
443 citing papers in PubMed, 16 syntheses or guidelines pooled it, 922 citations in OpenAlex.
- The effectiveness of digital therapeutics in improving sleep quality: a systematic review and network meta-analysis.BMC medicine · 2026Pooled it
- Mind-Body Therapies for Depression and Anxiety Symptoms in People with Cancer: A Systematic Review with Network Meta-Analysis.Current oncology reports · 2026Pooled it
- Efficacy and safety of lemborexant vs placebo in treating adults with insomnia disorder: a systematic review and meta-analysis of 1976 patients.Naunyn-Schmiedeberg's archives of pharmacology · 2025Pooled it
- Adverse Maternal and Fetal Outcomes Associated with Insomnia During Pregnancy: a Systematic Review and Meta-Analysis.Reproductive sciences (Thousand Oaks, Calif.) · 2025Pooled it
- Prevalence of sleep disorders in atopic dermatitis: a systematic review and meta-analysis.Archives of dermatological research · 2025Pooled it
- Comparative efficacy of interventions for insomnia in cancer patients: a systematic review and network meta-analysis.Sleep & breathing = Schlaf & Atmung · 2025Pooled it
- Auricular acupressure for insomnia in women with breast cancer: A systematic review and meta-analysis of randomized controlled trials.Medicine · 2025Pooled it
- Impact of probiotics on sleep quality and mood states in patients with insomnia: a systematic review and meta-analysis.Frontiers in microbiology · 2025Pooled it
- Global trends and hotspots in exercise therapy for insomnia research: bibliometric and visual analysis.Frontiers in neurology · 2025Pooled it
- Acupuncture for perimenopausal insomnia: a systematic review and meta-analysis.Frontiers in medicine · 2025Pooled it
- The effectiveness of aromatic extract on insomnia: a meta-analysis.Sleep & breathing = Schlaf & Atmung · 2024Pooled it
- Sex Differences in Insomnia and Circadian Rhythm Disorders: A Systematic Review.Medicina (Kaunas, Lithuania) · 2024Pooled it
- Sleep disorders and associated factors among medical students in the Middle East and North Africa: a systematic review and meta-analysis.Scientific reports · 2024Pooled it
- Evaluating the global prevalence of insomnia during pregnancy through standardized questionnaires and diagnostic criteria: a systematic review and meta-analysis.Frontiers in psychiatry · 2024Pooled it
- Different doses of dual orexin receptor antagonists in primary insomnia: a Bayesian network analysis.Frontiers in pharmacology · 2023Pooled it
- The prevalence and severity of insomnia symptoms during COVID-19: A global systematic review and individual participant data meta-analysis.Sleep medicine · 2022Pooled it
- Results of a pilot randomized controlled trial of CBT-I for veterans with serious mental illness and insomnia.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2026Trial
- Transcranial photobiomodulation improves sleep quality, reduces daytime sleepiness, and modulates delta power in chronic insomnia: a randomized controlled trial.Lasers in medical science · 2025Trial
- Pharmacokinetics, Pharmacodynamic, Safety and Tolerability of Fazamorexant, a Novel Dual Orexin Receptor Antagonist: Report of the First-in-Human Study.Drug design, development and therapy · 2025Trial
- Trial
383 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
Abstract
importanceInsomnia is one of the most prevalent health concerns in the population and in clinical practice. Clinicians may be reluctant to address insomnia because of its many potential causes, unfamiliarity with behavioral treatments, and concerns about pharmacologic treatments.
objectiveTo review the assessment, diagnosis, and treatment of insomnia in adults. EVIDENCE REVIEW: Systematic review to identify and summarize previously published quantitative reviews (meta-analyses) of behavioral and pharmacologic treatments for insomnia.
findingsInsomnia is a common clinical condition characterized by difficulty initiating or maintaining sleep, accompanied by symptoms such as irritability or fatigue during wakefulness. The prevalence of insomnia disorder is approximately 10% to 20%, with approximately 50% having a chronic course. Insomnia is a risk factor for impaired function, development of other medical and mental disorders, and increased health care costs. The etiology and pathophysiology of insomnia involve genetic, environmental, behavioral, and physiological factors culminating in hyperarousal. The diagnosis of insomnia is established by a thorough history of sleep behaviors, medical and psychiatric problems, and medications, supplemented by a prospective record of sleep patterns (sleep diary). Quantitative literature reviews (meta-analyses) support the efficacy of behavioral, cognitive, and pharmacologic interventions for insomnia. Brief behavioral interventions and Internet-based cognitive-behavioral therapy both show promise for use in primary care settings. Among pharmacologic interventions, the most evidence exists for benzodiazepine receptor agonist drugs, although persistent concerns focus on their safety relative to modest efficacy. Behavioral treatments should be used whenever possible, and medications should be limited to the lowest necessary dose and shortest necessary duration. CONCLUSIONS AND RELEVANCE: Clinicians should recognize insomnia because of its effects on function and health. A thorough clinical history is often sufficient to identify factors that contribute to insomnia. Behavioral treatments should be used when possible. Hypnotic medications are also efficacious but must be carefully monitored for adverse effects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.